BioNotebook: Xencor regains rights from Amgen; plus three other deals

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapy Areas